Ha habido 50 transacciones internas recientes registradas para Aeglea BioTherapeutics, Inc. (AGLE), incluyendo 35 compras y 8 ventas. El total de compras internas fue valorado en $29.2M y el total de ventas internas en $1.5M.
Internos destacados con actividad reciente incluyen Fairmount Funds Management Llc, Burrows Scott L, Turtle Cameron. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — AGLE
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2023-12-29 |
Fairmount Funds Management Llc |
10 Percent Owner |
Otro (Venta) |
3,435,480 |
- |
- |
- |
| 2023-12-22 |
Burrows Scott L |
Chief Financial Officer |
Concesión de RSU |
134,953 |
- |
- |
134,953 |
| 2023-12-07 |
Fairmount Funds Management Llc |
10 Percent Owner |
Concesión de RSU |
16,667 |
- |
- |
16,667 |
| 2023-11-24 |
Turtle Cameron |
Chief Executive Officer |
Conversión (Venta) |
18,086 |
- |
- |
- |
| 2023-11-24 |
Fairmount Funds Management Llc |
10 Percent Owner |
Conversión (Venta) |
85,887 |
- |
- |
- |
| 2023-11-24 |
Albers Jeffrey W. |
Director |
Conversión (Venta) |
859 |
- |
- |
- |
| 2023-11-22 |
Albers Jeffrey W. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-11-22 |
Albers Jeffrey W. |
Director |
Concesión de RSU |
50,000 |
$10.39 |
$519.5K |
50,000 |
| 2023-11-22 |
Stelzer Laurie |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-11-22 |
Stelzer Laurie |
Director |
Concesión de RSU |
50,000 |
$10.39 |
$519.5K |
50,000 |
| 2023-11-22 |
Turtle Cameron |
Chief Executive Officer |
Concesión de RSU |
374,000 |
$10.39 |
$3.89M |
374,000 |
| 2023-11-22 |
Albers Jeffrey W. |
Director |
Desconocido |
34,360 |
- |
- |
- |
| 2023-11-22 |
Albers Jeffrey W. |
Director |
Concesión de RSU |
50,000 |
$10.39 |
$519.5K |
50,000 |
| 2023-09-01 |
King-jones Heidy |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-09-01 |
King-jones Heidy |
See Remarks |
Concesión de RSU |
13,495,255 |
$0.58 |
$7.83M |
13,495,255 |
| 2023-09-01 |
Burrows Scott L |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-09-01 |
Burrows Scott L |
Chief Financial Officer |
Concesión de RSU |
10,121,441 |
$0.58 |
$5.87M |
10,121,441 |
| 2023-06-22 |
Magovcevic-liebisch Ivana |
Director |
Concesión de RSU |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Cox Russell J. |
Director |
Concesión de RSU |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Lawton Alison Frances |
Director |
Concesión de RSU |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Smith Hunter C |
Director |
Concesión de RSU |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Turtle Cameron |
Chief Operating Officer |
Disposición |
18,086,000 |
- |
- |
- |
| 2023-06-22 |
Henderson Michael Thomas |
Director |
Disposición |
1,950,000 |
$0.30 |
$585K |
- |
| 2023-06-22 |
Fairmount Funds Management Llc |
10 Percent Owner |
Desconocido |
1,950,000 |
$0.30 |
$585K |
- |
| 2023-06-22 |
Alspaugh Jonathan |
President and CFO |
Concesión de RSU |
19,787,969 |
$0.30 |
$5.94M |
19,787,969 |
| 2023-02-23 |
Hanley Jr. Michael Conick |
Chief Business Officer |
Concesión de RSU |
500,000 |
$0.44 |
$220K |
500,000 |
| 2023-02-23 |
Kastenmayer James Paul |
General Counsel |
Concesión de RSU |
500,000 |
$0.44 |
$220K |
500,000 |
| 2023-02-23 |
Alspaugh Jonathan |
Chief Financial Officer |
Concesión de RSU |
640,000 |
$0.44 |
$281.6K |
640,000 |
| 2023-02-23 |
Neuman Linda L |
Chief Medical Officer |
Concesión de RSU |
550,000 |
$0.44 |
$242K |
550,000 |
| 2022-11-29 |
Goldberg Jeff Marc |
President and CEO |
Desconocido |
- |
- |
- |
- |
| 2022-11-29 |
Goldberg Jeff Marc |
President and CEO |
Concesión de RSU |
1,884,838 |
- |
- |
1,884,838 |
| 2022-11-14 |
Neuman Linda L |
Chief Medical Officer |
Disposición |
- |
- |
- |
4,000 |
| 2022-11-14 |
Neuman Linda L |
Chief Medical Officer |
Concesión de RSU |
25,000 |
- |
- |
25,000 |
| 2022-08-25 |
Souza Marcio |
Director |
Compra Informativa |
90,000 |
$0.56 |
$50.47K |
90,000 |
| 2022-08-23 |
Sloan Leslie |
Chief Operating Officer |
Concesión de RSU |
130,000 |
$0.68 |
$88.4K |
130,000 |
| 2022-08-23 |
Hanley Jr. Michael Conick |
Chief Business Officer |
Concesión de RSU |
130,000 |
$0.68 |
$88.4K |
130,000 |
| 2022-08-23 |
Kastenmayer James Paul |
Interim CEO & General Counsel |
Disposición |
130,000 |
$7.03 |
$913.9K |
- |
| 2022-08-23 |
Kastenmayer James Paul |
Interim CEO & General Counsel |
Concesión de RSU |
130,000 |
$0.68 |
$88.4K |
130,000 |
| 2022-08-23 |
Alspaugh Jonathan |
Chief Financial Officer |
Concesión de RSU |
130,000 |
- |
- |
130,000 |
| 2022-06-08 |
Hanley Jr. Michael Conick |
Chief Commercial Officer |
Compra Informativa |
28,200 |
$0.71 |
$20.02K |
36,200 |
| 2022-06-07 |
Lawlis V Bryan |
Director |
Concesión de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Magovcevic-liebisch Ivana |
Director |
Concesión de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Mahatme Sandesh |
Director |
Concesión de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Cox Russell J. |
Director |
Concesión de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Smith Hunter C |
Director |
Concesión de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Shanafelt Armen |
Director |
Concesión de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Souza Marcio |
Director |
Concesión de RSU |
43,000 |
- |
- |
43,000 |
| 2022-06-07 |
Lawton Alison Frances |
Director |
Concesión de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-03-16 |
Quinn Anthony G. |
President & CEO |
Compra Informativa |
80,079 |
$2.34 |
$187.71K |
550,540 |
| 2022-03-15 |
Quinn Anthony G. |
President & CEO |
Compra Informativa |
42,417 |
$1.86 |
$78.94K |
473,461 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
